-
1
-
-
0028241857
-
Unknown primary carcinoma: Natural history and prognostic factors in 657 consecutive patients
-
Abbruzzese JL, Abbruzzese MC, Hess KR, et al. (1994) Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 12:1272-1280
-
(1994)
J Clin Oncol
, vol.12
, pp. 1272-1280
-
-
Abbruzzese, J.L.1
Abbruzzese, M.C.2
Hess, K.R.3
-
3
-
-
0000149365
-
Cancer of unknown primary site
-
Devita VT, Jr, Hellman S, Rosenberg SA (eds). Lippincott-Raven, Philadelphia
-
Greco FA, Hainsworth JD (1997) Cancer of unknown primary site. In: Devita VT, Jr, Hellman S, Rosenberg SA (eds) Principles and practice of oncology, fifth edn. Lippincott-Raven, Philadelphia, pp 2423-2443
-
(1997)
Principles and Practice of Oncology, Fifth Edn.
, pp. 2423-2443
-
-
Greco, F.A.1
Hainsworth, J.D.2
-
4
-
-
0023100568
-
Lack of value for cisplatin added to mitomyin-doxorubicin combination chemotherapy for carcinoma of unknown primary site
-
Eagan RT, Thermean TM, Rubin J (1987) Lack of value for cisplatin added to mitomyin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. Am J Clin Oncol 10:82-85
-
(1987)
Am J Clin Oncol
, vol.10
, pp. 82-85
-
-
Eagan, R.T.1
Thermean, T.M.2
Rubin, J.3
-
6
-
-
18544398495
-
Docetaxel for the treatment of anthracycline-resistant breast cancer
-
Ravdin PM (1997) Docetaxel for the treatment of nthracycline-resistant breast cancer. Semin Oncol 24(Suppl 1):s10-18-s10-21
-
(1997)
Semin Oncol
, vol.24
, Issue.SUPPL. 1
-
-
Ravdin, P.M.1
-
7
-
-
0030051216
-
Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer
-
Hudis CA, Seidman AD, Crown JPA, et al. (1996) Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer. J Clin Oncol 14:58-65
-
(1996)
J Clin Oncol
, vol.14
, pp. 58-65
-
-
Hudis, C.A.1
Seidman, A.D.2
Crown, J.P.A.3
-
8
-
-
0028827482
-
Phase II trial of docetaxel: A new highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer
-
Valero V, Holmes FA, Walters RS, et al. (1995) Phase II trial of docetaxel: a new highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer. J Clin Oncol 13:2886-2894
-
(1995)
J Clin Oncol
, vol.13
, pp. 2886-2894
-
-
Valero, V.1
Holmes, F.A.2
Walters, R.S.3
-
9
-
-
0031427450
-
Phase II trials of docetaxel in advanced ovarian cancer: An updated overview
-
Kaye SB, Piccart M, Aapro M (1997) Phase II trials of docetaxel in advanced ovarian cancer: an updated overview. Eur J Cancer 33:2167-2170
-
(1997)
Eur J Cancer
, vol.33
, pp. 2167-2170
-
-
Kaye, S.B.1
Piccart, M.2
Aapro, M.3
-
10
-
-
0030461988
-
Unknown primary carcinoma: Randomized studies are needed to identify optimal treatments and their benefits
-
Farrugia DC, Norman AR, Nicolson MC, et al. (1996) Unknown primary carcinoma: randomized studies are needed to identify optimal treatments and their benefits. Eur J Cancer 13:2256-2261
-
(1996)
Eur J Cancer
, vol.13
, pp. 2256-2261
-
-
Farrugia, D.C.1
Norman, A.R.2
Nicolson, M.C.3
-
11
-
-
0003486931
-
-
Offset Publication 48. World Health Organization, Geneva
-
World Health Organization (1979) WHO handbook for reporting results of cancer treatment. Offset Publication 48. World Health Organization, Geneva
-
(1979)
WHO Handbook for Reporting Results of Cancer Treatment
-
-
-
12
-
-
0032983316
-
Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer
-
Vasey PA, Paul J, Birt A, et al. (1999) Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer. J Clin Oncol 17:2069-2080
-
(1999)
J Clin Oncol
, vol.17
, pp. 2069-2080
-
-
Vasey, P.A.1
Paul, J.2
Birt, A.3
-
13
-
-
0031044607
-
Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors
-
Pank LC, Schellens JHM, Planting AST, et al. (1997) Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors. J Clin Oncol 15:1071-1079
-
(1997)
J Clin Oncol
, vol.15
, pp. 1071-1079
-
-
Pank, L.C.1
Schellens, J.H.M.2
Planting, A.S.T.3
-
14
-
-
0007548744
-
Phase I/II study of docetaxel and cisplatin in patients with previously untreated metastatic non-small-cell lung cancer
-
Karato A, Hayashi I, Segawa Y, et al. (1997) Phase I/II study of docetaxel and cisplatin in patients with previously untreated metastatic non-small-cell lung cancer, Lung Cancer 18 (Suppl 1):30
-
(1997)
Lung Cancer
, vol.30
, Issue.SUPPL. 1
-
-
Karato, A.1
Hayashi, I.2
Segawa, Y.3
|